Eltrombopag inhibits metastasis via targeting HuR protein in breast carcinoma

Author:

Chen Yao1,Zhang Rui1,Yang Liuqing1,Zhang Pei1,Wang Feiyun1,Zhu Yuying1,Zhang Jiange1

Affiliation:

1. Shanghai University of Traditional Chinese Medicine

Abstract

Abstract Background Metastatic of breast cancer is one of the leading causes of cancer-related death. HuR is an mRNA binding protein, which could regulate mRNA stability of multiple cancer-related genes, including metastasis-related genes Snail, Cox-2 and Vegf-c. Eltrombopag is a small molecule TPO-R agonist which has been demonstrated to inhibit tumor growth by targeting HuR protein. However, the effect and mechanisms of eltrombopag in breast cancer metastasis has not been fully investigated. This study aimed to investigated the role of eltrombopag in breast cancer metastasis. Methods Activity of eltrombopag on molecular level was detected with Electrophoretic mobility shift assay (EMSA) and Fluorescence polarization (FP). Scratch wound assay and transwell assays were carried out to verified cell migration and invasion. Moreover, mechanism of HuR-dependent inhibition of breast cancer metastasis was identified with qRT-PCR, mRNA stability assay, RNA immunoprecipitation analysis and luciferase assays. The effect of anti-tumor metastasis in vivo was investigated by in vivo imaging system. Results We found that HuR-AREs complexes were disrupted by eltrombopag at molecular levels. Functionally, eltrombopag suppressed 4T1 cell migration and invasion, inhibited macrophage-mediated lymphangiogenesis in vitro. Mechanistically, eltrombopag was verified to inhibit the expression of Snail, Cox-2, Vegf-c in 4T1 cells and Vegf-c in RAW264.7 cells through targeting HuR. Finally, eltrombopag exerts inhibitory effects in lung metastasis and lymph node metastasis in vivo. Conclusions Eltrombopag display anti-metastasis activity in breast cancer with HuR dependent manner, which may provide a novel application of eltrombopag and imply the multiple effects of HuR inhibitors in cancer therapy.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3